Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure

This publication has 52 references indexed in Scilit:

• Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
  BMJ, 1985
• Efficacy of prazosin in the management of chronic congestive heart failure: A 6-month randomized, double-blind, placebo-controlled study
  The American Journal of Cardiology, 1983
• Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: Relation between clinical response and left ventricular function at rest and during exercise
  Published by Elsevier ,1983
• Therapeutic application of prazosin in chronic refractory congestive heart failure: Tolerance and “tachyphylaxis” in perspective
  The American Journal of Medicine, 1981
• Ambulatory prazosin treatment of chronic congestive heart failure: Development of late tolerance reversible by higher dosage and interrupted substitution therapy
  American Heart Journal, 1981
• Long-term therapy of heart failure with prazosin: A randomized double blind trial
  Published by Elsevier ,1980
• Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure
  The American Journal of Cardiology, 1979
• Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart Failure
  Annals of Internal Medicine, 1979
• Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
  Circulation, 1979
• Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator Prazosin
  New England Journal of Medicine, 1977